Adam Fine serves as the Founder and Managing Partner at Windham Capital Partners since January 2006. Fine is actively involved in several organizations as a Board Observer, including ChromaCode, Inc., Upward Health, Personal Genome Diagnostics, Cureatr, Cartiva, Inc., and NUVAIRA, Inc. Additionally, Fine holds Board Member positions at andros and NeuSpera Medical Inc. Fine's educational background includes an MBA in Finance from New York University and a BA in International Relations from Boston University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices